Skip to main content

Featured article: Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study

New Content Item (1)Patients with chronic obstructive pulmonary disease (COPD) have a high incidence of cardiovascular disease including thromboembolisms. Fibrin degradation products, like D-dimer, have been associated with death from all causes in healthy individuals and COPD patients. The aim of this study is to determine the association between D-dimer levels and all-cause mortality and time being alive and out of a hospital, possible modifying effect of anticoagulant treatment, and distribution of D-dimer in patients with moderate to severe COPD.

Read the article

Pulmonary fibrosis: new insights

Edited by:
Paolo Spagnolo: University of Padua, Italy 
Argyrios Tzouvelekis: University of Patras, Greece

Submission Status: Open until 30 June 2024

Asthma: Towards a Cure

Guest Editor:
Reynold A. Panettieri: Rutgers Institute for Translational Medicine & Science, United States

Submission Status: Open until 31 May 2025

Coronavirus research collection

Click here for recent content published in Respiratory Research on COVID-19!

Trending articles

Click here to view the most shared articles in the last month!

Electronic cigarettes: Investigating the harms and benefits

Guest edited by Associate Editor, Professor Robert Bals (Saarland University, Germany), this series of articles provides newest research and comprehensive background information on e-cigarettes. The articles aim to address the needs of basic researchers, clinicians and other individuals that need up-to-data information on this topic.

Respiratory Research is pleased to still be accepting submissions for this thematic series.


About the Editors

Robert Bals

​​​​Prof. Bals is the director of the Saarland University’s Department of Pulmonology, where Prof. Bals focuses on teaching, research, and patient care. In the research area, Prof. Bals covers preclinical and clinical research and has contributed to 250 papers and several books. His research areas are inflammatory lung disease, asthma, COPD, and infection. In the basic science laboratory, Prof. Bals and his team investigate the mechanisms how the lung interacts with the environment including smoke, allergens, and microorganisms with a focus on stem cell biology and regeneration. In clinical research, he performs investigations in COPD, asthma, pneumonia and cystic fibrosis. He established and manages the German alpha-1-antitrypsin registry and is member of the steering committee of COSYCONET.

New Content ItemDale Tang

Prof. Tang is a Professor of the Department of Molecular and Cellular Physiology at Albany Medical College, New York, United States of America. He is Director of Cytoskeletal Signaling and Asthma Research Program at the school. His research is involved in asthma, pulmonary arterial hypertension, lung inflammation, smooth muscle biochemistry, physiology and molecular biology. His research has been funded by multiple NIH grants and other funding agencies. 

Submit your review

Respiratory Research welcomes review articles on a variety of different topics relating to the scope of the journal. Submit your review today.

For further queries or to discuss the limited funds which may be available to cover the article-processing charge, please contact the editorial team.

Aims and scope

Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases.

As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Editorial board

Robert Bals, Saarland University, Germany
Dale D. Tang, Albany Medical College, USA

Associate Editors
Sureshbabu Angara, Norton Thoracic Institute, Creighton University School of Medicine, USA
Tiago Alfaro, University of Coimbra, Portugal
Steven An, Rutgers University, USA
Takuya Aoki, Tokai University School of Medicine, Japan
Cristina Ardura-Garcia, University of Bern, Switzerland
Paolo Bironzo, University of Turin, Italy
Francesco Blasi, University of Milan, Italy
Su Bo, Shanghai Pulmonary Hospital, China
Agnes Boots, Maastricht University, Netherlands
Arnaud Bourdin, University of Montpellier, France
Mario Cazzola, University of Rome Tor Vergata, Italy
Kuei-Pin Chung, National Taiwan University College of Medicine, Taiwan
Suzanne Cloonan, Weill Cornell Medicine, USA
Taylor Cohen, MedImmune, USA
Jeanine D'Armiento, Columbia University College of Physicians and Surgeons, USA
Olivier Danhaive, University of California San Francisco, USA
Rafael E. de la Hoz, Icahn School of Medicine at Mount Sinai, USA
Sara De Matteis, Imperial College London, UK
Deepak Deshpande, Thomas Jefferson University, USA
Marta Drummond, University of Porto, Portugal
Orianne Dumas, Inserm, France
Elaine Fuertes, Imperial College London, UK
Eric Garshick, VA Boston Healthcare System, USA
Jose Gomez Villalobos, Yale University, USA
Andrea Gramegna, University of Milan, Italy
Kathleen Haley, Brigham and Women's Hospital, USA
Qinghua Hu, Huazhong Science and Technology University, Tongji Medical College, China
Marco Idzko, Medical University of Vienna, Austria
Dany Jaffuel, Regional University Hospital of Montpellier, France
Riitta Kaarteenaho, Oulu University Hospital, Finland
Victor Laubach, University of Virginia, USA
Anna Lavizzari, Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico, Italy
Mareike Lehmann, Helmholtz Center Munich, Germany
Micheal Mac Aogain, St. James's Hospital and Trinity College Dublin, Ireland
Arnaud Mailleux, INSERM, France
Federico Mei, Polytechnic University of Marche, Italy
Nobuaki Miyahara, Okayama University, Japan 
Yasuhiko Nishioka, Tokushima University, Japan
Stylianos Orfanos, National and Kapodistrian University of Athens, Greece
Bi-Yun Qian, Shanghai Jiao Tong University, China
Giacomo Sgalla, Fondazione Policlinico Universitario A.Gemelli IRCCS, Italy
Ilias Siempos, Weill Cornell Medicine, USA
Giovanni Sotgiu, University of Sassari, Italy
Pei Yee Tiew, Singapore General Hospital, Singapore
David Tingay, The Royal Children's Hospital, Australia
Sara Tomassetti, Careggi Hospital, Italy
Argyris Tzouvelekis, University of Patras, Greece
Niki Ubags, Centre Hospitalier Universitaire Vaudois, Switzerland
Johan Verbraecken, Antwerp University Hospital, Belgium
Tao Wang, Huazhong University of Science and Technology, China
Tilo Winkler, Massachusetts General Hospital, USA
Xiaobo Zhou, Brigham and Women's Hospital, USA

View more

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.9 - 5-year Impact Factor
    1.444 - SNIP (Source Normalized Impact per Paper)
    1.753 - SJR (SCImago Journal Rank)

    2022 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    150 days submission to accept (Median)

    2022 Usage 
    9,098 Altmetric mentions